COVID vaccines for 5 to 11 year olds are inching closer. Here's what we know so far

By Vasso Apostolopoulos, Professor of Immunology and Associate Provost, Research Partnerships, Victoria University
Athina (Tina) Soulis, Strategic Advisor, Neuroscience Trials Australia, Florey Institute of Neuroscience and Mental Health, The University of Melbourne
Jack Feehan, Research Officer - Immunology and Translational Research, Victoria University
Maja Husaric, Senior Lecturer; MD, Victoria University

Regulators are currently reviewing the safety and efficacy data of the Pfizer vaccine for five to 11 year olds before deciding whether to approve its use in this age group.

Read complete article

~	Why the pathology bulk-billing campaign is more about driving industry profits than saving you money

~	Restoring coastal habitat boosts wildlife numbers by 61% – but puzzling failures mean we can still do better

~	TikTok fears point to larger problem: Poor media literacy in the social media age

~	Donald Trump trial: why it took so long to select a jury and how the process is different to the UK

~	Bitcoin is halving again – what does that mean for the cryptocurrency and the market?

~	Liz Truss: an economist explains what she got wrong (and what she’s actually right about)

~	Domestic politics will be a key factor in how far things escalate between Israel and Iran

~	Peter Higgs’ famous particle discovery is now at the heart of strategies to unlock the secrets of the universe

~	Why you shouldn’t be afraid to start running after middle age

~	The world’s oldest conjoined twins have died – what we know about this rare condition